Australia: The Hydroponics Company appoints CCO
In 2016 Mrs Ormsby undertook a consulting assignment assessing the global medicinal cannabis market and provided strategic advice which supported the subsequent legislation of medicinal cannabis in Victoria.
Mrs Ormsby stated she is excited to join THC at this stage of rapid expansion into the growing Australian market and looks forward to leveraging her pharmaceutical industry experience to facilitate patient access to medicinal cannabis for therapeutic use. Her goal is to focus on the objectives and priorities of the company that will achieve optimal results for all stakeholders and make a meaningful difference to the lives of Australian patients.
THC’s Group Chief Executive Officer, David Radford said: “We are delighted to have an executive of Debbie’s calibre with her impressive track record and enormous commercial experience join THC. Her career in the development of pharmaceutical markets both locally and internationally bring the required skills to help THC develop innovative solutions that bring the prescribing physicians and patients together to facilitate the access to high quality medicinal cannabis solutions."
For more information:
The Hydroponics Company
Suite 305, Level 3, 35 Lime Street
Sydney, NSW 2000 Australia
www.thcl.com.au